🥇 First rule of investing? Know when to save! Up to 55% off InvestingPro before BLACK FRIDAYCLAIM SALE

Pfizer's COVID-19 vaccine to arrive in Canada soon, PM Trudeau hails "good news"

Published 2020-12-10, 06:34 p/m
© Reuters. FILE PHOTO: Pfizer vaccine photo illustration
PFE
-

OTTAWA (Reuters) - The first 30,000 doses of Pfizer (NYSE:PFE)'s Inc's COVID-19 vaccine are set to arrive in Canada soon, allowing authorities to kick off a campaign to crush a second wave, officials said on Thursday.

Canada on Wednesday became only the third country in the world, after Britain and Bahrain, to approve the vaccine.

"To all Canadians - if you're feeling relieved and hopeful, you're not alone. This is the good news we all needed," Prime Minister Justin Trudeau said.

"But remember, this is only the first step in what will be a massive project over a long winter."

The shipments will be sent to 14 special distribution sites across what is the world's second largest country by area, much of it remotely populated. The military has been drafted in to assist.

Major-General Dany Fortin, who is in charge of the logistics, said the first doses should start to arrive at the sites on Monday.

© Reuters. FILE PHOTO: Canada's Prime Minister Justin Trudeau attends a news conference in Ottawa

Canada has so far recorded 435,330 cases of COVID-19, including 12,983 deaths. Most of the major provinces have reimposed some restrictions on businesses and gatherings to combat a second wave.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.